Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Over the last decade, there has been a growing appreciation of the importance of identifying and treating cognitive impairment associated with bipolar disorder, since it persists in remission periods. Evidence indicates that neurocognitive dysfunction may significantly influence patients' psychosocial outcomes. An ever-increasing body of research seeks to achieve a better understanding of potential moderators contributing to cognitive impairment in bipolar disorder in order to develop prevention strategies and effective treatments. This review provides an overview of the available data from studies examining treatments for cognitive dysfunction in bipolar disorder as well as potential novel treatments, from both pharmacological and psychological perspectives. All these data encourage the development of further studies to find effective strategies to prevent and treat cognitive impairment associated with bipolar disorder. These efforts may ultimately lead to an improvement of psychosocial functioning in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Coupled with the results of other small studies involving other interventions, these findings suggest that there is considerable hope in addressing cognitive and functional deficits in BD.118”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 2×
“Taking into account the scarcity of adequately powered randomized trials and discrepant results on research in this field, it will be highly recommendable to conduct further studies investigating treatments targeting cognition in bipolar patients following the Consolidated Standards for Reporting Trials (Moher et al.,…”
BackgroundYatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Stern, Y. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.03.004 · Cited by 2,943
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationCuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377 · cited 1×
“This framework incorporates genetics, neuroimaging, and cognitive sciences for a new classification of mental disorders (Cuthbert, 2014), where the cognitive system is among the proposed higher order domains.”
MethodBora, E., Yucel, M., & Pantelis, C. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.009 · Cited by 1,022 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundA meta-analysis of cognitive deficits in euthymic patients with bipolar disorder
Robinson, L. J., Thompson, J. M., Gallagher, P., Goswami, U., Young, A. H., Ferrier, I. N., & Moore, P. B. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.016 · Cited by 962 · cited 1×
“Data from different meta-analyses confirm that most patients with bipolar disorder show neurocognitive dysfunction, even during euthymia (Robinson et al., 2006; Bourne et al., 2013; Bortolato et al., 2015).”
Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives
Arts, B., Jabben, N., Krabbendam, L., & van Os, J. (2008) · Psychological Medicine · doi:10.1017/s0033291707001675 · Cited by 707 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundBourne, C., Aydemir, Ö., Balanzá‐Martínez, V., Bora, E., Brissos, S., Cavanagh, J. T. O., Clark, L., Cubukcuoglu, Z., Dias, V. V., Dittmann, S., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12133 · Cited by 644
Self-citationThe Kraepelinian dichotomy – going, going … but still not gone
Craddock, N., & Owen, M. J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.073429 · Cited by 587
Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
Allostatic load in bipolar disorder: Implications for pathophysiology and treatment
Kapczinski, F., Vieta, E., Andreazza, A. C., Frey, B. N., Gomes, F. A., Tramontina, J., Kauer-Sant’Anna, M., Grassi-Oliveira, R., & Post, R. M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.005 · Cited by 480 · cited 1×
“During the last decade, different staging model approaches have been proposed for BD (Berk et al., 2007; Kapczinski et al., 2008).”
BackgroundSelf-citationKurtz, M. M., & Gerraty, R. T. (2009) · Neuropsychology · doi:10.1037/a0016277 · Cited by 433 · cited 2×
“…from moderate to high, are attention, verbal learning and memory, and executive functions, whereas premorbid intelligence appears to be preserved (Kurtz and Gerraty, 2009; International Journal of Neuropsychopharmacology (2017) 20(8): 670–680 doi:10.1093/ijnp/pyx032 Advance Access Publication:…”
BackgroundInfluentialvan Gorp, W. G., Altshuler, L., Theberge, D. C., Wilkins, J., & Dixon, W. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.41 · Cited by 413 · cited 1×
“…neurocognitive performance are substance use disorders, anxiety, the attention deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al.,…”
BackgroundEmpirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications
Burdick, K. E., Russo, M., Frangou, S., Mahon, K., Braga, R. J., Shanahan, M., & Malhotra, A. K. (2014) · Psychological Medicine · doi:10.1017/s0033291714000439 · Cited by 355
Bora, E., & Pantelis, C. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu198 · Cited by 341 · cited 2×
“Some of these neurocognitive deficits seem to be present not only in the early course of the illness (Torres et al., 2010; Lee et al., 2014; Bora and Pantelis, 2015) but also in premorbid stages before illness onset (Martino et al., 2015).”
BackgroundEfficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study
Torrent, C., Bonnin, C. D. M., Martínez-Arán, A., Valle, J., Amann, B. L., González-Pinto, A., Crespo, J. M., Ibáñez, Á., Garcia-Portilla, M. P., Tabarés-Seisdedos, R., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070971 · Cited by 330
Self-citationBonnín, C. M., Martínez-Arán, A., Torrent, C., Pacchiarotti, I., Rosa, A. R., Franco, C., Murru, A., Sanchez-Moreno, J., & Vieta, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.05.014 · Cited by 328
Self-citationYoung, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318 · cited 1×
“Mifepristone, a corticosteroid receptor antagonist, showed preliminary evidence to improve spatial working memory in depressed bipolar patients in 2 studies, the enhancement occurring in the absence of an improvement in depressed mood (Young et al., 2004; Watson et al., 2012).”
BackgroundRosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv082 · Cited by 315
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
Carvalho, A. F., Bortolato, B., Miskowiak, K., Vieta, E., & Köhler, C. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s76700 · Cited by 306 · cited 1×
“Data from different meta-analyses confirm that most patients with bipolar disorder show neurocognitive dysfunction, even during euthymia (Robinson et al., 2006; Bourne et al., 2013; Bortolato et al., 2015).”
Self-citationSlyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448957 · Cited by 278 · cited 1×
“In this line, probiotics are being tested as procognitive agents in other psychiatric conditions given their antiinflammatory properties (Slyepchenko et al., 2017), so they appear as a new potential treatment to examine in bipolar illness.”
BackgroundSelf-citationSetting the stage: from prodrome to treatment resistance in bipolar disorder
Berk, M., Conus, P., Lucas, N., Hallam, K., Malhi, G. S., Dodd, S., Yatham, L. N., Yung, A., & McGorry, P. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00484.x · Cited by 238 · cited 1×
“During the last decade, different staging model approaches have been proposed for BD (Berk et al., 2007; Kapczinski et al., 2008).”
BackgroundMeta‐analysis of predictors of favorable employment outcomes among individuals with bipolar disorder
Tse, S., Chan, S., Ng, K. L., & Yatham, L. N. (2014) · Bipolar Disorders · doi:10.1111/bdi.12148 · Cited by 234
Social cognition in euthymic bipolar disorder: systematic review and meta‐analytic approach
Samamé, C., Martino, D. J., & Strejilevich, S. A. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01808.x · Cited by 231 · cited 2×
“Importantly, 2 points need to be kept in mind regarding social cognition: first, there is a large number of available tasks that evaluate social cognition domains with different levels of complexity and quality; second, some findings point out that other neurocognitive deficits may influence social cognitive performan…”
BackgroundEffects of Lithium on Cognitive Performance: A Meta-Analysis
Wingo, A. P., Wingo, T. S., Harvey, P. D., & Baldessarini, R. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04972 · Cited by 229 · cited 1×
“Besides, there is some controversy regarding neurotoxic and neuroprotective effects of several agents, as lithium (Wingo et al., 2009).”
BackgroundLópez‐Jaramillo, C., Lopera‐Vásquez, J., Gallo, A., Ospina‐Duque, J., Bell, V., Torrent, C., Martínez‐Arán, A., & Vieta, E. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00835.x · Cited by 224 · cited 2×
“…mentioned before, many of the cross-sectional studies point toward an association between number of affective episodes and neurocognitive impairment, suggesting a progressive cognitive decline, especially with the recurrence of manic episodes (López-Jaramillo et al., 2010; Hellvin et al., 2012).”
BackgroundSelf-citationBALANZAMARTINEZ, V, RUBIO, C., SELVAVERA, G., MARTINEZARAN, A., SANCHEZMORENO, J., SALAZARFRAILE, J., VIETA, E., & TABARESSEISDEDOS, R. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.019 · Cited by 223 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundSelf-citationAreas of controversy in neuroprogression in bipolar disorder
Passos, I. C., Mwangi, B., Vieta, E., Berk, M., & Kapczinski, F. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12581 · Cited by 208
Self-citationSpecificity of Cognitive Deficits in Bipolar Disorder versus Schizophrenia
Daban, C., Martinez-Aran, A., Torrent, C., Tabarés-Seisdedos, R., Balanzá-Martínez, V., Salazar-Fraile, J., Selva-Vera, G., & Vieta, E. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000090891 · Cited by 207 · cited 1×
“…out that the neurocognitive impairment profile observed in patients with BD is similar to that shown in patients with schizophrenia although in a lesser extent; therefore, differences between the two disorders seem to be predominantly quantitative rather than qualitative (Daban et al., 2006).”
ResultSelf-citationDeckersbach, T., Nierenberg, A. A., Kessler, R., Lund, H. G., Ametrano, R. M., Sachs, G., Rauch, S. L., & Dougherty, D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00110.x · Cited by 204
Subthreshold symptoms in bipolar disorder: Impact on neurocognition, quality of life and disability
Bonnín, C. M., Sánchez-Moreno, J., Martínez-Arán, A., Solé, B., Reinares, M., Rosa, A. R., Goikolea, J. M., Benabarre, A., Ayuso-Mateos, J. L., Ferrer, M., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.012 · Cited by 190 · cited 1×
“Another step toward mitigating cognitive impairment will be via the treatment of those subclinical symptoms that may also impact cognitive function and psychosocial outcome, even at low levels (Bonnin et al., 2011).”
BackgroundSelf-citationPsychosocial interventions in bipolar disorder: What, for whom, and when
Reinares, M., Sánchez-Moreno, J., & Fountoulakis, K. N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.12.017 · Cited by 184 · cited 1×
“Overall, mindfulness appears as a useful intervention for the reduction of anxiety symptoms and, probably, to reduce depression symptoms (Reinares et al., 2014).”
BackgroundSelf-citationGoodwin, G. M., Martinez-Aran, A., Glahn, D. C., & Vieta, E. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.005 · Cited by 180 · cited 1×
“It is not well established yet whether neurocognitive deficits are due to neurodevelopmental abnormalities, to the illness progression, or if they reflect part of both processes (Goodwin et al., 2008).”
BackgroundSelf-citationBaune, B. T., & Malhi, G. S. (2015) · Bipolar Disorders · doi:10.1111/bdi.12341 · Cited by 177 · cited 1×
“Available evidence underscores that cognitive dysfunction is a critical mediator of adverse psychosocial outcomes in BD and a predictor of unfavorable employment outcomes (Tse et al., 2014; Baune and Malhi, 2015;).”
BackgroundA meta-analysis of neuropsychological functioning in first-episode bipolar disorders
Lee, R. S. C., Hermens, D. F., Scott, J., Redoblado-Hodge, M. A., Naismith, S. L., Lagopoulos, J., Griffiths, K. R., Porter, M. A., & Hickie, I. B. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.06.019 · Cited by 172 · cited 1×
“Some of these neurocognitive deficits seem to be present not only in the early course of the illness (Torres et al., 2010; Lee et al., 2014; Bora and Pantelis, 2015) but also in premorbid stages before illness onset (Martino et al.”
BackgroundLongitudinal course of cognitive deficits in bipolar disorder: A meta-analytic study
Samamé, C., Martino, D. J., & Strejilevich, S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.028 · Cited by 168
Long-Term Outcome of Cognitive Impairment in Bipolar Disorder
Torrent, C., Martinez-Arán, A., Bonnin, C. D. M., Reinares, M., Daban, C., Solé, B., Rosa, A. R., Tabarés-Seisdedos, R., Popovic, D., Salamero, M., et al. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07471 · Cited by 164
Self-citationSocial cognition in schizophrenia in comparison to bipolar disorder: A meta-analysis
Bora, E., & Pantelis, C. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.018 · Cited by 160 · cited 2×
“Patients with schizophrenia also significantly underperform bipolar patients in social cognitive tasks, such as emotion recognition and theory of mind similarly to findings for other neurocognitive tasks (Bora and Pantelis, 2016).”
BackgroundResultJensen, J. H., Knorr, U., Vinberg, M., Kessing, L. V., & Miskowiak, K. W. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.018 · Cited by 160
Clinical Staging in Bipolar Disorder
Rosa, A. R., Magalhães, P. V. D. S., Czepielewski, L. S., Sulzbach, M. F. V., Goi, P. D., Vieta, E., Gama, C. S., & Kapczinski, F. P. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08625 · Cited by 155 · cited 1×
“Therefore, an early identification of which patients will develop a neuroprogressive disorder as well as the link with staging models are some of the challenges in the upcoming years (Rosa et al., 2014; Passos et al., 2016).”
BackgroundSelf-citationAnaya, C., Torrent, C., Caballero, F. F., Vieta, E., Bonnín, C. D. M., Ayuso‐Mateos, J. L., & CIBERSAM Functional Remediation Group (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12535 · Cited by 152
Self-citationTorres, I. J., DeFreitas, V. G., DeFreitas, C. M., Kauer‐Sant’Anna, M., Bond, D. J., Honer, W. G., Lam, R. W. M., & Yatham, L. N. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04997yel · Cited by 147 · cited 1×
“Some of these neurocognitive deficits seem to be present not only in the early course of the illness (Torres et al., 2010; Lee et al., 2014; Bora and Pantelis, 2015) but also in premorbid stages before illness onset (Martino et al., 2015).”
BackgroundSelf-citationWatson, S., Gallagher, P., Porter, R. J., Smith, M. S., Herron, L. J., Bulmer, S., Young, A. H., & Ferrier, I. N. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.029 · Cited by 145 · cited 1×
“Mifepristone, a corticosteroid receptor antagonist, showed preliminary evidence to improve spatial working memory in depressed bipolar patients in 2 studies, the enhancement occurring in the absence of an improvement in depressed mood (Young et al., 2004; Watson et al., 2012).”
BackgroundNeurocognition in bipolar disorders—A closer look at comorbidities and medications
Balanzá‐Martínez, V., Selva, G., Martínez‐Arán, A., Prickaerts, J., Salazar, J., González-Pinto, A. M., Vieta, E., & Tabarés‐Seisdedos, R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.018 · Cited by 144 · cited 1×
“…the attention deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et al., 2015; I. Torres,…”
BackgroundSelf-citationForcada, I., Mur, M., Mora, E., Vieta, E., Bartrés‐Faz, D., & Portella, M. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.018 · Cited by 141
Self-citationBora, E. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12410 · Cited by 138 · cited 1×
“As some authors suggest, the neurocognitive variability might also reflect an etiological heterogeneity in BD including potential different subtypes associated with different genetic susceptibility factors (Bora, 2016).”
BackgroundChengappa, K. N. R., Bowie, C. R., Schlicht, P. J., Fleet, D., Brar, J. S., & Jindal, R. D. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08413 · Cited by 135 · cited 1×
“Another compound demonstrating a positive effect in some cognitive measures in euthymic or subsyndromal bipolar patients was the extract of Withania somnifera, an herbal medicine with antioxidant and neuroprotective effects (Chengappa et al., 2013).”
BackgroundSocial cognition and interaction training (SCIT) for outpatients with bipolar disorder
Lahera, G., Benito, A., Montes, J. M. G., Fernández-Liria, A., Olbert, C. M., & Penn, D. L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.032 · Cited by 134
Demant, K. M., Vinberg, M., Kessing, L. V., & Miskowiak, K. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127955 · Cited by 133
Goss, A. J., Kaser, M., Costafreda, S. G., Sahakian, B. J., & Fu, C. H. Y. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08560 · Cited by 133 · cited 1×
“For instance, modafinil is an effective augmentation strategy for acute depressive episodes (Goss et al., 2013).”
BackgroundMillan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132 · cited 1×
“It is also remarkable that neurocognitive deficits are not specific of BD, and they may be considered as a common dimension across disparate psychiatric disorders, thus a trans-nosological domain (Millan et al., 2015; Vieta, 2016).”
BackgroundBora, E., Hıdıroğlu, C., Özerdem, A., Kaçar, Ö. F., Sarísoy, G., Arslan, F. C., Aydemır, Ö., Tas, Z. C., Vahip, S., Atalay, A., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.04.002 · Cited by 126
Harel, E. V., Zangen, A., Roth, Y., Reti, I. M., Braw, Y., & Levkovitz, Y. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.510893 · Cited by 125
The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study
Amoretti, S., Bernardo, M., Bonnín, C. D. M., Bioque, M., Cabrera, B., Mezquida, G., Solé, B., Vieta, E., & Torrent, C. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.07.003 · Cited by 123 · cited 1×
“Interestingly, a higher cognitive reserve has also been demonstrated to be associated with better neurocognitive, functional, and clinical outcomes in first psychotic episodes and to be predictive of functioning at 2-year follow-up of this group of patients (Amoretti et al., 2016).”
BackgroundSelf-citationExcellent lithium responders have normal cognitive functions and plasma BDNF levels
RYBAKOWSKI, J. K., & Suwalska, A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000404 · Cited by 120 · cited 2×
“…fact, an interesting study showed that a small sample of excellent lithium responders exhibited normal cognitive functioning and plasma brain derived neurotrophic factor levels compared with the remaining lithium patients where the effect of lithium was not optimal (Rybakowski and Suwalska, 2010).”
BackgroundHawkins, K. A., Mohamed, S., & Woods, S. W. (1999) · Psychological Medicine · doi:10.1017/s0033291798006990 · Cited by 120
Bonnín, C. D. M., Torrent, C., Arango, C., Amann, B. L., Solé, B., González-Pinto, A. M., Crespo, J. M., Tabarés‐Seisdedos, R., Reinares, M., Ayuso‐Mateos, J. L., et al. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.162123 · Cited by 120
Self-citationThe effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder
Yim, C. Y., Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Brietzke, E. M., & McIntyre, R. S. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.004 · Cited by 117 · cited 1×
“…deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et al., 2015; I. Torres, unpublished observations).”
BackgroundThe effects of physical exercise in schizophrenia and affective disorders.
Malchow, B., Reich-Erkelenz, D., Oertel-Knöchel, V., Keller, K., Hasan, A., Schmitt, A., Scheewe, T. W., Cahn, W., Kahn, R. S., & Falkai, P. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0423-2 · Cited by 111 · cited 1×
“The results obtained across other psychiatric or neurological conditions, as well as on aging, suggest that aerobic physical exercise may also have unequivocal beneficial effects on cognitive functioning in BD, though no studies are available in this population (Kucyi et al., 2010; Malchow et al., 2013).”
ResultFranke, A. G., Gränsmark, P., Agricola, A., Schühle, K., Rommel, T., Sebastian, A., Balló, H. E., Gorbulev, S., Gerdes, C., Frank, B., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.006 · Cited by 109
Cognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review
Keefe, R. S. E., McClintock, S. M., Roth, R. M., Doraiswamy, P. M., Tiger, S., & Madhoo, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08609 · Cited by 107 · cited 1×
“Lastly, as a whole, antidepressants seem to have beneficial effects in reducing cognitive impairment, especially with a positive effect on psychomotor speed and delayed recall, with no significant differences between different antidepressant classes (Keefe et al., 2014; Rosenblat et al., 2016).”
BackgroundCognitive effects of adjunctive N-acetyl cysteine in psychosis
Rapado‐Castro, M., Dodd, S., Bush, A. I., Malhi, G. S., Skvarc, D., On, Z. X., Berk, M., & Dean, O. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716002932 · Cited by 107
Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.
Gualtieri, C. T., & Johnson, L. G. (2006) · PubMed · Cited by 106
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., Vaccarino, A., MacQueen, G., Lewis, G. F., & Kennedy, S. H. (2012) · Bipolar Disorders · doi:10.1111/bdi.12006 · Cited by 104 · cited 1×
“However, this component did not show any therapeutic effect neither on the primary cognition outcomes nor on other secondary cognitive outcomes (memory measures) (McIntyre et al., 2012).”
BackgroundNeurocognitive functioning in patients recently diagnosed with bipolar disorder
Hellvin, T., Sundet, K. S., Simonsen, C., Aminoff, S. R., Lagerberg, T. V., Andreassen, O. A., & Melle, I. S. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01004.x · Cited by 103 · cited 2×
“…mentioned before, many of the cross-sectional studies point toward an association between number of affective episodes and neurocognitive impairment, suggesting a progressive cognitive decline, especially with the recurrence of manic episodes (López-Jaramillo et al., 2010; Hellvin et al., 2012).”
BackgroundBerk, M., Dean, O. M., Cotton, S., Gama, C. S., Kapczinski, F. P., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Moss, K., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-91 · Cited by 103 · cited 1×
“Results from a large, randomized, double-blind controlled trial showed that N-acetyl cysteine (NAC) as an add-on treatment in patients with BD failed to find benefits in cognitive functioning (Berk et al., 2008, 2012; Dean et al., 2012).”
BackgroundMindfulness-Based Cognitive Therapy for Bipolar Disorder: Effects on Cognitive Functioning
Stange, J. P., Eisner, L. R., Hölzel, B. K., Peckham, A., Dougherty, D. D., Rauch, S. L., Nierenberg, A. A., Lazar, S. W., & Deckersbach, T. (2011) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000407964.34604.03 · Cited by 102
Cognition as a target in schizophrenia, bipolar disorder and depression
Martinez-Aran, A., & Vieta, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.007 · Cited by 101 · cited 1×
“The study of neurocognitive impairment, its causes and consequences, as well as the development of new therapeutic strategies to manage or even prevent these kinds of deficits is currently one of the hottest areas of research in bipolar disorder (BD) (Martinez-Aran and Vieta, 2015).”
BackgroundSelf-citationCognitive variability in bipolar II disorder: who is cognitively impaired and who is preserved
Solé, B., Jiménez, E., Torrent, C., Bonnín, C. D. M., Torres, I., Reinares, M., Priego, Á., Salamero, M., Colom, F., Varo, C., et al. (2016) · Bipolar Disorders · doi:10.1111/bdi.12385 · Cited by 101
Self-citationAn individual task meta-analysis of social cognition in euthymic bipolar disorders
Samamé, C., Martino, D. J., & Strejilevich, S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.055 · Cited by 100 · cited 1×
“In the last 10 years, there is also growing evidence for impairment in some social cognition domains even during periods of remission (Samamé et al., 2012, 2015).”
BackgroundMiskowiak, K. W., Carvalho, A. F., Vieta, E., & Kessing, L. V. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.08.011 · Cited by 100
Self-citationRecombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder
Miskowiak, K. W., Ehrenreich, H., Christensen, E. M., Kessing, L. V., & Vinberg, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08839 · Cited by 99 · cited 2×
“Erythropoietin was another adjunctive treatment that improved some secondary and tertiary cognitive measures related to sustained attention, working memory, executive function, and recognition of facial expression in euthymic patients, but not in verbal memory, which was the primary outcome (Miskowiak et al., 2014).”
BackgroundMartino, D. J., Samamé, C., Ibáñez, A. M., & Strejilevich, S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.044 · Cited by 98 · cited 1×
“, 2014; Bora and Pantelis, 2015) but also in premorbid stages before illness onset (Martino et al., 2015).”
BackgroundDeficient inhibitory control as an outcome of childhood trauma
Marshall, D., Passarotti, A. M., Ryan, K. A., Kamali, M., Saunders, E. F. H., Pester, B., McInnis, M. G., & Langenecker, S. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.013 · Cited by 95
Depp, C. A., Strassnig, M., Mausbach, B. T., Bowie, C. R., Wolyniec, P. S., Thornquist, M. H., Luke, J. R., McGrath, J. A., Pulver, A. E., Patterson, T. L., et al. (2014) · Bipolar Disorders · doi:10.1111/bdi.12200 · Cited by 93 · cited 1×
“…deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et al., 2015; I. Torres, unpublished observations).”
BackgroundSocial Cognition and Global Functioning in Bipolar Disorder
Lahera, G., Ruiz-Murugarren, S., Iglesias, P., Ruiz-Bennásar, C., Herrería, E., Montes, J. M. G., & Fernández-Liria, A. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182438eae · Cited by 87 · cited 1×
“Because social cognition also seems to be involved in psychosocial functioning, an interest in developing strategies to enhance social cognition has emerged over the last years (Lahera et al., 2012).”
BackgroundThe increasing burden of mental and neurological disorders
Catalá-López, F., Gènova-Maleras, R., Vieta, E., & Tabarés‐Seisdedos, R. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.04.001 · Cited by 86
Self-citationThe neurocognitive performance of drug‐free and medicated euthymic bipolar patients do not differ
Goswami, U., Sharma, A., Varma, A., Gulrajani, C., Ferrier, I. N., Young, A. H., Gallagher, P., Thompson, J. M., & Moore, P. B. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01390.x · Cited by 85 · cited 1×
“side effects of pharmacological treatments, studies conducted with medication-free bipolar patients indicate that cognitive impairment is caused by the illness impact, and few effects are due to the medication per se (Goswami et al., 2009).”
BackgroundBurdick, K. E., Ketter, T. A., Goldberg, J. F., & Calabrese, J. R. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14cs09399 · Cited by 83
Volkert, J., Kopf, J., Kazmaier, J., Glaser, F., Zierhut, K. C., Schiele, M. A., Kittel-Schneider, S., & Reif, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.017 · Cited by 83 · cited 1×
“…deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et al., 2015; I. Torres, unpublished observations).”
BackgroundBurdick, K. E., Braga, R. J., Nnadi, C. U., Shaya, Y., Stearns, W. H., & Malhotra, A. K. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07299 · Cited by 82 · cited 1×
“Pramipexole, a dopaminergic agonist, could have a beneficial effect on processing speed and working memory, but it was only observed in those euthymic bipolar I patients in a posthoc analysis of an 8-week, double-blind, placebo-controlled trial (Burdick et al., 2012).”
BackgroundBora, E., Veznedaroğlu, B., & Vahip, S. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.007 · Cited by 80
High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment
Grande, I., Sánchez‐Moreno, J., Solé, B., Jiménez, E., Torrent, C., Bonnín, C. D. M., Varo, C., Tabarés‐Seisdedos, R., Balanzá‐Martínez, V., Valls, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.012 · Cited by 80
Self-citationYatham, L. N., Mackala, S. A., Basivireddy, J., Ahn, S., Walji, N., Hu, C., Lam, R. W. M., & Torres, I. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30046-9 · Cited by 80 · cited 2×
“Lastly, given the preliminary support for cognitive enhancement of lurasidone in patients with schizophrenia, a randomized, openlabel pilot trial has examined the efficacy of this agent as an add-on treatment in comparison with treatment as usual (TAU) in euthymic bipolar I patients (Yatham et al., 2017).”
ResultSelf-citationTreatment of Functional Impairment in Patients with Bipolar Disorder
Sánchez‐Moreno, J., Martínez‐Arán, A., & Vieta, E. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0752-3 · Cited by 79 · cited 1×
“After achieving the remission of an acute episode, it will be necessary to use an effective pharmacotherapy for relapse prevention, implement psychoeducation programs to avoid multiple episodes, and promote healthy habits (Sanchez-Moreno et al., 2017).”
BackgroundSelf-citationSánchez‐Moreno, J., Martínez‐Arán, A., Colom, F., Scott, J. L., Tabarés‐Seisdedos, R., Sugranyes, G., Torrent, C., Daban, C., Benabarre, A., Goikolea, J. M., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04302 · Cited by 76 · cited 1×
“…substance use disorders, anxiety, the attention deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et…”
BackgroundSelf-citationSolé, B., Bonnín, C. D. M., Mayoral, M., Amann, B. L., Torres, I., González-Pinto, A. M., Jiménez, E., Crespo, J. M., Colom, F., Tabarés‐Seisdedos, R., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.05.010 · Cited by 76 · cited 1×
“The intervention was also effective in bipolar II patients (Solé et al., 2015).”
BackgroundSelf-citationThe Management of Cognitive Impairment in Bipolar Disorder: Current Status and Perspectives
Sanches, M., Bauer, I. E., Galvez, J. F., Zunta‐Soares, G. B., & Soares, J. C. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000120 · Cited by 74
Methylene blue treatment for residual symptoms of bipolar disorder: Randomised crossover study
Alda, M., McKinnon, M. C., Blagdon, R. A., Garnham, J. S., MacLellan, S., O’Donovan, C., Hájek, T., Nair, C., Dursun, S. M., & MacQUEEN, G. M. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.173930 · Cited by 72 · cited 2×
“There is a series of other investigated compounds with, at least for now, negative results on cognition, as methylene blue (Alda et al., 2017) or with only improvement in subjective cognition such as donepezil, therefore with a lower evidence of effect on cognitive performance (Gildengers et al.”
BackgroundAerobic Physical Exercise as a Possible Treatment for Neurocognitive Dysfunction in Bipolar Disorder
Kucyi, A., Alsuwaidan, M. T., Liauw, S. S. L., & McIntyre, R. S. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.11.2228 · Cited by 70 · cited 1×
“…obtained across other psychiatric or neurological conditions, as well as on aging, suggest that aerobic physical exercise may also have unequivocal beneficial effects on cognitive functioning in BD, though no studies are available in this population (Kucyi et al., 2010; Malchow et al., 2013).”
BackgroundBonnín, C. D. M., Reinares, M., Martínez‐Arán, A., Balanzá‐Martínez, V., Solé, B., Torrent, C., Tabarés‐Seisdedos, R., García‐Portilla, M. P., Ibáñez, Á., Amann, B. L., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001713 · Cited by 69 · cited 1×
“Secondary analysis showed that the intervention also improved neurocognitive outcomes in the subsample of cognitively impaired patients (Bonnin et al., 2015).”
BackgroundSelf-citationKaşer, M., Deakin, J., Michael, A., Zapata, C. D., Bansal, R., Ryan, D., Cormack, F. K., Rowe, J. B., & Sahakian, B. J. (2016) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2016.11.009 · Cited by 66
Fountoulakis, K. Ν., Vieta, E., Young, A. H., Yatham, L. N., Grunze, H., Blier, P., Moeller, H. J., & Kasper, S. F. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw072 · Cited by 64
Self-citationLevy, B., Monzani, B. A., Stephansky, M. R., & Weiss, R. D. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.09.009 · Cited by 63 · cited 1×
“…performance are substance use disorders, anxiety, the attention deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et…”
BackgroundAbdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals
Lackner, N., Bengesser, S., Birner, A., Painold, A., Fellendorf, F. T., Platzer, M., Reininghaus, B., Weiss, E. M., Mangge, H., McIntyre, R. S., et al. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1046917 · Cited by 62 · cited 1×
“…deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et al., 2015; I. Torres, unpublished observations).”
BackgroundBersani, F. S., Minichino, A., Bernabei, L., Spagnoli, F., Vergnani, L., Corrado, A., Ines, I. T., Biondi, M., & Chiaie, R. D. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s79108 · Cited by 59
Effects of N‐acetyl cysteine on cognitive function in bipolar disorder
Dean, O. M., Bush, A. I., Copolov, D. L., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02392.x · Cited by 58 · cited 1×
“Results from a large, randomized, double-blind controlled trial showed that N-acetyl cysteine (NAC) as an add-on treatment in patients with BD failed to find benefits in cognitive functioning (Berk et al., 2008, 2012; Dean et al., 2012).”
BackgroundIosifescu, D. V., Moore, C. M., Deckersbach, T., Tilley, C. A., Ostacher, M. J., Sachs, G. S., & Nierenberg, A. A. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00090.x · Cited by 54 · cited 1×
“Although some of them have reported a potential benefit in verbal memory, even for those patients receiving electroconvulsive therapy, these studies have important caveats and merit further investigation (Matthews et al., 2008; Ghaemi et al., 2009; Iosifescu et al., 2009; Matthews et al., 2013).”
ResultKozicky, J.-M., Torres, I. J., Silveira, L. E., Bond, D. J., Lam, R. W., & Yatham, L. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08928 · Cited by 52 · cited 1×
“This cognitive impairment seems to be present from the first manic episode, although episode-free patients could improve cognitively in the year following the first manic episode (Kozicky et al., 2014).”
BackgroundSelf-citationYager, J., & Feinstein, R. E. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15nr10476 · Cited by 51
de la Serna, E., Vila, M., Sánchez‐Gistau, V., Moreno, D. M., Romero, S., Sugranyes, G., Baeza, I., Llorente, C., Rodríguez-Toscano, E., Sánchez‐Gutiérrez, T., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.014 · Cited by 48
Li, J., Zuo, W., Fu, R., Xie, G., Kaur, A., Bekker, A., & Ye, J. H. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw050 · Cited by 46
Bersani, F. S., Minichino, A., Capra, Bonanno, Pannese, Salviati, Chiaie, R. D., & Biondi, M. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s27025 · Cited by 45 · cited 1×
“Deep transcranial magnetic stimulation (DTMS) is a novel alternative to repetitive TMS, which has been associated with small shortterm improvement in sustained attention and larger improvement in spatial and visuospatial memory in unipolar depression (Minichino et al., 2012).”
BackgroundThe impact of galantamine on cognition and mood during electroconvulsive therapy: A pilot study
Matthews, J., Blais, M. A., Park, L., WELCH, C. A., Baity, M. R., Murakami, J. L., Sklarsky, K. G., Homberger, C. H., & Fava, M. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.06.002 · Cited by 40 · cited 1×
“Although some of them have reported a potential benefit in verbal memory, even for those patients receiving electroconvulsive therapy, these studies have important caveats and merit further investigation (Matthews et al., 2008; Ghaemi et al., 2009; Iosifescu et al., 2009; Matthews et al., 2013).”
ResultBobo, W. V., Woodward, N. D., Sim, M. Y., Jayathilake, K., & Meltzer, H. Y. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.015 · Cited by 39
Zyto, S., Jabben, N., Schulte, P. F. J., Regeer, B. J., & Kupka, R. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.029 · Cited by 39
Staging and psychosocial early intervention in bipolar disorder
Vieta, E. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00205-9 · Cited by 36 · cited 2×
“Altogether, these data suggest that interventions to enrich cognitive reserve in the early stages of the illness might result in minimizing the detrimental neuropsychological and functional impact caused (Vieta, 2015).”
BackgroundSelf-citationSánchez‐Moreno, J., Bonnín, C. D. M., González-Pinto, A. M., Amann, B. L., Solé, B., Balanzá‐Martínez, V., Arango, C., Jiménez, E., Tabarés‐Seisdedos, R., García‐Portilla, M. P., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.010 · Cited by 36
Self-citationGildengers, A. G., Butters, M. A., Chisholm, D., Reynolds, C. F., & Mulsant, B. H. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1962 · Cited by 35 · cited 1×
“…is a series of other investigated compounds with, at least for now, negative results on cognition, as methylene blue (Alda et al., 2017) or with only improvement in subjective cognition such as donepezil, therefore with a lower evidence of effect on cognitive performance (Gildengers et al., 2008).”
BackgroundGhaemi, S. N., Gilmer, W. S., Dunn, R. T., Hanlon, R. E., Kemp, D. E., Bauer, A., Chriki, L. S., Filkowski, M. M., & Harvey, P. D. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a497d7 · Cited by 35 · cited 1×
“Although some of them have reported a potential benefit in verbal memory, even for those patients receiving electroconvulsive therapy, these studies have important caveats and merit further investigation (Matthews et al., 2008; Ghaemi et al., 2009; Iosifescu et al., 2009; Matthews et al., 2013).”
ResultMatthews, J., Siefert, C. J., Blais, M. A., Park, L. T., Siefert, C. J., WELCH, C. A., DuBois, C. M., van Nieuwenhuizen, A. O., Rooney, K., Seabrook, R. C., et al. (2013) · Journal of Ect · doi:10.1097/yct.0b013e31828b3523 · Cited by 32 · cited 1×
“Although some of them have reported a potential benefit in verbal memory, even for those patients receiving electroconvulsive therapy, these studies have important caveats and merit further investigation (Matthews et al., 2008; Ghaemi et al., 2009; Iosifescu et al., 2009; Matthews et al., 2013).”
ResultTranscranial direct current stimulation to enhance cognition in euthymic bipolar disorder
Martin, D. M., Chan, H., Alonzo, A., Green, M. J., Mitchell, P. B., & Loo, C. K. A. (2015) · Bipolar Disorders · doi:10.1111/bdi.12350 · Cited by 32
Neurocognitive Training in Patients with Bipolar Disorders: Current Status and Perspectives
Fuentes-Durá, I., Balanzá‐Martínez, V., Ruíz, J. C., Martínez‐Arán, A., Girón, M., Solé, B., Sánchez‐Moreno, J., Gómez-Beneyto, M., Vieta, E., & Tabarés‐Seisdedos, R. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000335821 · Cited by 27
Self-citationStrawbridge, R., Fish, J. E., Halari, R., Hodsoll, J. P., Reeder, C., Macritchie, K., McCrone, P., Wykes, T., & Young, A. H. (2016) · Trials · doi:10.1186/s13063-016-1472-4 · Cited by 26 · cited 1×
“Concerning this topic, Lewandowski and colleagues (2016) have published a study protocol for assessing the efficacy of an internet-based cognitive remediation program for patients with BD type I, similarly to Strawbridge and co-workers (Strawbridge et al., 2016).”
BackgroundVieta, E. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12624 · Cited by 23
Self-citationEl cerebro visceral: trastorno bipolar y microbiota
Salagre, E., Vieta, E., & Grande, I. (2017) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2017.02.001 · Cited by 23 · cited 1×
“A better knowledge of its role in BD as well as a progress of preventive and/or therapeutic perspectives for the modulation of gut microbiota is also warranted (Salagre et al., 2017).”
BackgroundSelf-citationSilva, K. L., Rovaris, D. L., Guimarães-da-Silva, P. O., Victor, M. M., Salgado, C. A. I., Vitola, E. S., Contini, V., Bertuzzi, G. P., Picon, F. A., Karam, R. G., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12158 · Cited by 21 · cited 1×
“…deficit hyperactivity disorder, and overweight or obesity (van Gorp et al., 1998; Levy et al., 2008; Sanchez-Moreno et al., 2009; Balanzá-Martínez et al., 2010; Yim et al., 2012; Depp et al., 2014; Silva et al., 2014; Lackner et al., 2015; Volkert et al., 2015; I. Torres, unpublished observations).”
BackgroundNeurocognitive Correlates of the Course of Bipolar Disorder
Budde, M., & Schulze, T. G. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000016 · Cited by 19
Breitborde, N. J. K., Dawson, S. C., Woolverton, C. B., Dawley, D., Bell, E. K., Norman, K. R., Polsinelli, A. J., Bernstein, B., Mirsky, P., Pletkova, C., et al. (2014) · BMC Psychology · doi:10.1186/s40359-014-0041-4 · Cited by 17 · cited 1×
“In this line, there is a published protocol study about a randomized controlled trial to examine the utility of combining cognitive remediation and d-cycloserine (an NMDA receptor partial agonist) in individuals with BD (Breitborde et al., 2014).”
BackgroundThe visceral brain: Bipolar disorder and microbiota
Salagre, E., Vieta, E., & Grande, I. (2017) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2017.02.005 · Cited by 10
Self-citationLewandowski, K. E., Sperry, S. H., Öngür, D., Cohen, B. M., Norris, L. A., & Keshavan, M. S. (2016) · Trials · doi:10.1186/s13063-016-1275-7 · Cited by 8
Caso clínico : Tratamiento antipsicótico y aspectos neurocognitivos
Solé, B., & Jiménez, E. (2015) · Psiquiatría Biológica · doi:10.1016/s1134-5934(15)30021-x · Cited by 1 · cited 1×
“After reviewing the available literature concerning BD treatment, Solé and Jimenez concluded that no specific atypical antipsychotic appears better than the others with regard to its cognitive profile (Solé and Jiménez, 2015).”
MethodSelf-citationMartin, D. M., Chan, H. N., Green, M. J., Mitchell, P. B., Alonzo, A., & Loo, C. K. A. (2015) · Brain stimulation · doi:10.1016/j.brs.2015.01.183 · Cited by 1 · cited 1×
“On the other hand, an intraindividual cross-over study failed to prove the efficacy of a single session of tDCS improving working memory and attention in euthymic bipolar patients (Martin et al., 2015).”
Background
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“Coupled with other small studies involving other interventions, there is considerable hope in addressing cognitive and functional deficits in BD (118).”
Self-citationMalhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614
“Cognitive remediation has typically been provided in a structured group format, teaching skills and problem-solving strategies to compensate for cognition-related challenges, but other modalities including digitally delivered interventions are under development (Sole et al., 2017).”
BackgroundEarly Intervention in Bipolar Disorder
Vieta, E., Salagre, E., Grande, I., Carvalho, A. F., Fernandes, B. S., Berk, M., Birmaher, B., Tohen, M., & Suppes, T. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17090972 · Cited by 354
Self-citationEvidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
Carvalho, A. F., Solmi, M., Sanches, M., Machado, M. O., Stubbs, B., Ajnakina, O., Sherman, C., Sun, Y. R., Liu, C. S., Brunoni, A. R., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0835-5 · Cited by 204
Self-citationPhytochemicals and cognitive health: Are flavonoids doing the trick?
Bakoyiannis, I., Daskalopoulou, A., Pergialiotis, V., & Perrea, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.086 · Cited by 185
Metadata
- Authors
- Solé, B., Jiménez, E., Torrent, C., Reinares, M., Bonnin, C. D. M., Torres, I., Varo, C., Grande, I., Valls, E., Salagre, E., Sanchez-Moreno, J., Martinez-Aran, A., Carvalho, A. F., & Vieta, E.
- Affiliations
- Universidade Federal do Ceará (BR)
- Corresponding author
- Vieta, Eduard
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-11
- Volume
- 20
- Issue
- 8
- Pages
- 670-680
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5570032
- OpenAlex
- W2613431376
- Cited by
- 299
- References
- 125
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 48 · 2023: 28 · 2022: 40 · 2021: 37 · 2020: 34 · 2019: 24 · 2018: 21 · 2017: 1
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Generalitat de Catalunya (2014_ SGR_398)
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- Ministerio de Economía y Competitividad (PI12/00912, PI12/, CPI14/00175)
- Centro de Investigación Biomédica en Red de Salud Mental
- Instituto de Salud Carlos III (PI11/, CPI14/00175, 00012, PI15/00330, JR15/00012, 2008-2011)
- European Regional Development Fund
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, cognitive impairment, neurocognitive impairment, cognitive impairment prevention, pharmacotherapy, psychological intervention, psychosocial functioning
- MeSH terms
- Bipolar Disorder, Humans, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
